Molecular targeted therapy for hepatocellular carcinoma bench to bedside 7th japan korea liver symposium kyoto july 2010 special topic issue digestive diseases 2011 vol 29 no 3 kudo hino kim han lee isbn 9783805597616 kostenloser versand fur alle bucher mit versand und verkauf duch amazon wahlen sie ihre cookie einstellungen wir verwenden cookies und ahnliche tools . Buy molecular targeted therapy for hepatocellular carcinoma bench to bedside 7th japan korea liver symposium kyoto july 2010 special topic issue digestive . Currently hcc has only one systemic molecular targeted therapy the multi kinase inhibitor sorafenib the standard of care for advanced liver cancer is limited because sorafenib can expand the median life expectancy of patients for only 1 year thus there is an urgent need to develop a novel molecular targeted therapy to improve therapeutic outcomes for hcc hccs are phenotypically and genetically heterogeneous tumors driven by diverse molecular mechanisms however hccs exhibit certain . Download free molecular targeted therapy for hepatocellular carcinoma bench to bedside 7th japan korea liver symposium kyoto molecular targeted therapy of cancer the progress and molecular targeted therapies in hepatocellular carcinoma authors josep m llovet corresponding author e mail address jmllovetclinicubes mount sinai . Molecular targeted therapy for advanced hepatocellular carcinoma hcc has changed markedly although sorafenib was used in clinical practice as the first molecular targeted agent in 2007 the sharpe and asian pacific trials demonstrated that sorafenib only improved overall survival os by approximately 3 months in patients with advanced hcc compared with placebo